1100 WINTER STREET, WALTHAM, MA
Market cap: $49.5M (3/17/2025)
Price: $9.81
Announces Oversubscribed $50.0 Million Private Placement
Investor Presentation
Reports Third Quarter 2025 Financial Results and Provides Business Updates
Matthew Gall Appointed CFO of Kalaris Therapeutics, Effective Nov 3, 2025
Shareholder votes
Reports Second Quarter 2025 Financial Results and Provides Business Updates
Annual Report to Security Holders
Material disclosure
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-4/A
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Delisting Amendment
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement